corgenix Message Board - Msg: 24564645

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : corgenix

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: RikRichter	5/6/2008 11:21:47 AM
	of 191

Corgenix to Host Conference Call to Discuss Third Quarter Fiscal 2008 Results Tuesday May 6, 9:15 am ET DENVER, May 6 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX - News), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, May 15, 2008 at 4:00 PM EDT to discuss the Company's financial and operating performance for its third quarter 2008 and the status of the Company's product development and marketing activities. Corgenix invites all those interested in hearing management's discussion of the quarterly results to join the call by dialing: US attendees: (800) 894-5910 International attendees: +1 785 424 1052 Conference code is: CORGENIX A question and answer session will follow the presentation by Corgenix management. A replay will be available for 30 days following the call by dialing (800) 723-0394 for U.S. participants and +1 402 220 2649 for international participants. About Corgenix Medical Corporation Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next